Common Contracts
2 similar Convertible Note contracts by GT Biopharma, Inc.
CONVERTIBLE NOTE DUE JANUARY 31, 2021Convertible Note • December 28th, 2020 • GT Biopharma, Inc. • Pharmaceutical preparations • New York
THIS CONVERTIBLE NOTE is a duly authorized and validly issued Note of GT BIOPHARMA, INC., a Delaware corporation, (“Borrower”), having its principal place of business at 9350 Wilshire Blvd, Suite 203, Beverly Hills, CA 90212, due January 31, 2021 (the “Maturity Date”) (this note, the “Note”).
CONVERTIBLE NOTE DUE DECEMBER 19, 2020Convertible Note • June 19th, 2020 • GT Biopharma, Inc. • Pharmaceutical preparations • New York
THIS CONVERTIBLE NOTE is one of a series of duly authorized and validly issued Notes of GT BIOPHARMA, INC., a Delaware corporation, (“Borrower”), having its principal place of business at 9350 Wilshire Blvd, Suite 203, Beverly Hills, CA 90212, due December 19, 2020 (the “Maturity Date”) (this note, the “Note” and, collectively with the other notes of such series, the “Notes”).
